72% of GP consortia ``will develop drug formularies:'' poll
72% of medicines management payers at Primary Care Trusts believe that GP consortia will develop their drug own formularies, a new poll has found.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the gastric cancer drug market -- driven by the launch of several targeted agents over the next few years -- will more than double from approximately $700 million in 2008 to nearly $1.5 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.